PRINCIPLES OF COLLABORATION. The parties agree to adopt the following principles when carrying out the Project (Principles):
PRINCIPLES OF COLLABORATION. The parties agree to adopt the following principles of collaboration when working together (Principles):
PRINCIPLES OF COLLABORATION. The Partners agree to adopt the following principles when carrying out the Project
PRINCIPLES OF COLLABORATION. (1) It is necessary that the COLLABORATION PARTNER complies with each of the follow- ing requirements, otherwise GMC
PRINCIPLES OF COLLABORATION. The Councils agree to act in good faith and to adopt the behaviours set out in Part 2 of Schedule 1 when working jointly.
PRINCIPLES OF COLLABORATION. 1 To establish and adhere to the governance structure set out in this Agreement to ensure that activities are delivered and actions taken as required.
PRINCIPLES OF COLLABORATION. 1. The Centre's scientific activities will constitute a joint programme carried out by both organizations in accordance with the terms of this Agreement. They agree to maintain the purpose and functions of the Centre as set forth in paragraphs 2 and 3 of this Article.
PRINCIPLES OF COLLABORATION. The Parties agree to adopt the following principles when carrying out the Post Contract Award Project Phase (Principles):
PRINCIPLES OF COLLABORATION. 3.1 This collaborative procedure is applicable to: ■ pharmaceutical products that have been assessed and inspected by WHO/PQT in line with the procedures and standards available at xxx.xxx.xxx/xxxxxxx (“Information for applicants”) and have been found to be acceptable in principle for procurement by UN agencies as listed in the List of WHO prequalified medicines, available at www. xxx.xxx/xxxxxxx. The Procedure is not applicable to pharmaceutical products that have been listed as prequalified on the basis of approval by stringent regulatory authorities (SRAs).2 For such products the principal part of the assessment has been performed by SRAs and WHO/PQT is not in possession of assessment and inspection reports that can be shared; ■ vaccines that have been assessed and inspected by WHO/PQT in line with the procedures and standards available at xxxx://xxx. xxx.xxx/xxxxxxxxxxxx_xxxxxxxxx/xxxxxxx_xxxxxxx/xx_xxxxxx/xx/ and have been found to be acceptable in principle for procurement by UN agencies as listed in the List of WHO prequalified vaccines, available at xxxx://xxx.xxx.xxx/immunization_standards/vaccine_ quality/PQ_vaccine_list_en/en/. This Procedure is applicable to 2 Products listed as prequalified according to the procedure described in the Guidelines on submission of documentation for prequalification of finished pharmaceutical products approved by stringent regulatory authorities. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: forty‑eighth report. Geneva: World Health Organization; 2014: Annex 5 (WHO Technical Report Series, No. 986). vaccines that successfully passed either the standard or streamlined prequalification process: xxxx://xxx.xxx.xxx/immunization_ standards/vaccine_quality/pq_revision2010/en/). Although the Procedure mostly serves to accelerate the assessment and registration of prequalified multisource (generic) pharmaceutical products it is applicable to vaccines and any pharmaceutical product for which the safety and efficacy has been documented to WHO/PQT by the submission of preclinical and clinical data. The Procedure has three major stakeholders: WHO/PQT, interested NRAs and those WHO PQ holders or applicants3 who agree that this Procedure is used for applications for national registration of their WHO-prequalified product submitted to an NRA.
PRINCIPLES OF COLLABORATION. The Parties agree that, to the extent which it is reasonably practicable, this Agreement shall operate on a collaborative basis and to this end each Party agrees to use all reasonable endeavours to adhere to the Principles of Collaboration.
